IT201700045353A1 - Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi - Google Patents

Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi

Info

Publication number
IT201700045353A1
IT201700045353A1 IT102017000045353A IT201700045353A IT201700045353A1 IT 201700045353 A1 IT201700045353 A1 IT 201700045353A1 IT 102017000045353 A IT102017000045353 A IT 102017000045353A IT 201700045353 A IT201700045353 A IT 201700045353A IT 201700045353 A1 IT201700045353 A1 IT 201700045353A1
Authority
IT
Italy
Prior art keywords
prodromic
absorbence
research
determination
solid tumors
Prior art date
Application number
IT102017000045353A
Other languages
English (en)
Inventor
Giuseppe Mucci
Original Assignee
Bioscience Services S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioscience Services S R L filed Critical Bioscience Services S R L
Priority to IT102017000045353A priority Critical patent/IT201700045353A1/it
Priority to KR1020197034851A priority patent/KR102507439B1/ko
Priority to PCT/IB2017/054231 priority patent/WO2018197934A1/en
Priority to CN201780090026.1A priority patent/CN110621789A/zh
Priority to EP17780202.2A priority patent/EP3615682A1/en
Priority to JP2019555004A priority patent/JP6998611B2/ja
Priority to US16/607,993 priority patent/US20210108270A1/en
Priority to SG11201909723T priority patent/SG11201909723TA/en
Publication of IT201700045353A1 publication Critical patent/IT201700045353A1/it
Priority to US17/822,484 priority patent/US20230124836A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/50—Mutagenesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT102017000045353A 2017-04-26 2017-04-26 Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi IT201700045353A1 (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT102017000045353A IT201700045353A1 (it) 2017-04-26 2017-04-26 Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi
KR1020197034851A KR102507439B1 (ko) 2017-04-26 2017-07-13 고형 종양의 개시의 유전적 상태 전구증증을 조사하고 확인하는 방법
PCT/IB2017/054231 WO2018197934A1 (en) 2017-04-26 2017-07-13 Method for searching and identifying a genetic condition prodromal of the onset of solid tumors
CN201780090026.1A CN110621789A (zh) 2017-04-26 2017-07-13 用于搜索和鉴定发生实体瘤的前驱遗传状况的方法
EP17780202.2A EP3615682A1 (en) 2017-04-26 2017-07-13 Method for searching and identifying a genetic condition prodromal of the onset of solid tumors
JP2019555004A JP6998611B2 (ja) 2017-04-26 2017-07-13 固形腫瘍の発症の前駆的遺伝子状態を探索および特定する方法
US16/607,993 US20210108270A1 (en) 2017-04-26 2017-07-13 Method for searching and identifying a genetic condition prodromal of the onset of solid tumors
SG11201909723T SG11201909723TA (en) 2017-04-26 2017-07-13 Method for searching and identifying a genetic condition prodromal of the onset of solid tumors
US17/822,484 US20230124836A1 (en) 2017-04-26 2022-08-26 System using a method for searching and identifying a genetic condition prodromal of the onset of solid tumors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000045353A IT201700045353A1 (it) 2017-04-26 2017-04-26 Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi

Publications (1)

Publication Number Publication Date
IT201700045353A1 true IT201700045353A1 (it) 2018-10-26

Family

ID=59859466

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102017000045353A IT201700045353A1 (it) 2017-04-26 2017-04-26 Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi

Country Status (8)

Country Link
US (2) US20210108270A1 (it)
EP (1) EP3615682A1 (it)
JP (1) JP6998611B2 (it)
KR (1) KR102507439B1 (it)
CN (1) CN110621789A (it)
IT (1) IT201700045353A1 (it)
SG (1) SG11201909723TA (it)
WO (1) WO2018197934A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220405917A1 (en) * 2021-06-18 2022-12-22 Case Western Reserve University Combination of features from biopsies and scans to predict prognosis in sclc
WO2023012382A1 (es) * 2021-08-03 2023-02-09 Genetracer Biotech, S.L. Método de detección temprana de biomarcadores de tumores sólidos mediante biopsia líquida

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130143747A1 (en) * 2011-12-05 2013-06-06 Myriad Genetics, Incorporated Methods of detecting cancer
US20160102358A1 (en) * 2014-10-14 2016-04-14 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with cancer risk
US20160130648A1 (en) * 2014-11-12 2016-05-12 Neogenomics Laboratories, Inc. Deep sequencing of peripheral blood plasma dna as a reliable test for confirming the diagnosis of myelodysplastic syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902099C (en) 2013-03-08 2020-06-02 F. Hoffmann-La Roche Ag Egfr mutation blood testing
US10262755B2 (en) * 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
WO2016127944A1 (en) 2015-02-10 2016-08-18 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
JP6995625B2 (ja) 2015-05-01 2022-01-14 ガーダント ヘルス， インコーポレイテッド 診断方法
EP3443066A4 (en) * 2016-04-14 2019-12-11 Guardant Health, Inc. EARLY DETECTION METHODS FOR CANCER

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130143747A1 (en) * 2011-12-05 2013-06-06 Myriad Genetics, Incorporated Methods of detecting cancer
US20160102358A1 (en) * 2014-10-14 2016-04-14 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with cancer risk
US20160130648A1 (en) * 2014-11-12 2016-05-12 Neogenomics Laboratories, Inc. Deep sequencing of peripheral blood plasma dna as a reliable test for confirming the diagnosis of myelodysplastic syndrome

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DE MATTOS-ARRUDA LETICIA ET AL: "Cell-free circulating tumour DNA as a liquid biopsy in breast cancer", MOLECULAR ONCOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 10, no. 3, 17 December 2015 (2015-12-17), pages 464 - 474, XP029432258, ISSN: 1574-7891, DOI: 10.1016/J.MOLONC.2015.12.001 *
JEFFREY GAGAN ET AL: "Next-generation sequencing to guide cancer therapy", GENOME MEDICINE, vol. 7, no. 1, 29 July 2015 (2015-07-29), XP055421971, DOI: 10.1186/s13073-015-0203-x *
MARK SAUSEN ET AL: "Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients", NATURE COMMUNICATIONS, vol. 6, no. 7686, 7 July 2015 (2015-07-07), pages 1 - 6, XP055326405, DOI: 10.1038/ncomms8686 *

Also Published As

Publication number Publication date
JP2020518234A (ja) 2020-06-25
CN110621789A (zh) 2019-12-27
US20230124836A1 (en) 2023-04-20
JP6998611B2 (ja) 2022-01-18
KR20190141236A (ko) 2019-12-23
US20210108270A1 (en) 2021-04-15
WO2018197934A1 (en) 2018-11-01
KR102507439B1 (ko) 2023-03-08
SG11201909723TA (en) 2019-11-28
EP3615682A1 (en) 2020-03-04

Similar Documents

Publication Publication Date Title
MA50636A (fr) Compositions et procédés pour inhiber l'activité d'arginase
SI3580208T1 (sl) Derivati 2-(3-(1H-benzo(d)imidazol-1-il)propil)piperidin-3-ol in sorodne spojine kot zaviralci PRS za zdravljenje na primer raka
IT201700026199A1 (it) Impianto e metodo per la realizzazione di articoli ceramici
DK3255042T3 (da) Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme
ZA202003981B (en) Process for the preparation of 2-(5-methoxyisochroman-1 -yl)-4,5-dihydro-1 h-imidazole and the hydrogensulfate salt thereof
IT201700093172A1 (it) Metodo per l'identificazione precoce di riacutizzazioni di broncopneumopatia cronica ostruttiva
MA49006A (fr) Inhibiteurs d'ip6k
EP3504204A4 (en) INDAZOLYL-L, 2,4-THIADIAZOLAMINE AND RELATED COMPOUNDS FOR INHIBITING RHO-ASSOCIATED PROTEIN KINASES AND FOR TREATING DISEASES
MA42497A (fr) Procédés et compositions pour la régulation sélective de l'expression protéique
MA50906A (fr) Inhibiteurs d'immunoprotéasome
IT201700045353A1 (it) Metodo per la ricerca e l'individuazione di una condizione genetica prodromica all'insorgenza di tumori solidi
FR3030276B1 (fr) Compositon et procede pour diminuer ou traiter une inflammation de la cavite orale
IT201800003334A1 (it) Metodo ed impianto per la realizzazione di imballi
IT201700105483A1 (it) Metodo per la diagnosi e la prognosi di patologie neurodegenerative e neuroinfiammatorie
IT201700051294A1 (it) Dispositivo e metodo per la raccolta, la conservazione e/o il trasporto di campioni biologici
LT3648761T (lt) Telmisartanas, skirtas kačių hipertenzijos profilaktikai arba gydymui
ES2874259T8 (es) Composiciones y procedimientos para la detección de Trichomonas vaginalis
ITUA20162517A1 (it) Composizione per la conservazione/fissazione di materiale biologico
CY1121189T1 (el) Παραγωγο αζολο βενζολιου και κρυσταλλος αυτου
SG11202107605SA (en) Sensor chip and methods thereof
IT201700058491A1 (it) Metodo per il trasporto e lo stoccaggio di lastre ceramiche
IT201600115018A1 (it) Procedimento per la determinazione di una probabilita' di sosta di un oggetto in una rete stradale e apparecchio di comando
FR3039990B1 (fr) Procede d'encapsulation
IT201700107672A1 (it) Macchina perfezionata per il trattamento, la movimentazione e/o la gestione di manufatti laminari.
IT201700024609A1 (it) Metodo e kit per la diagnosi e/o prognosi di tumori non ematologici